These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1739299)

  • 1. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis.
    Prussick R; Ali MA; Rosenthal D; Guyatt G
    Arch Dermatol; 1992 Feb; 128(2):210-3. PubMed ID: 1739299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E and dapsone-induced hemolysis.
    Kelly JW; Scott J; Sandland M; Van der Weyden MB; Marks R
    Arch Dermatol; 1984 Dec; 120(12):1582-4. PubMed ID: 6508329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitamin E as protective agent against hemolysis in leprosy patients under dapsone treatment].
    Lardo MM; Díaz NB; Artaza JR; Carbia CD; Nazer R; Valdez R
    Medicina (B Aires); 1997; 57(2):150-4. PubMed ID: 9532824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenium, glutathione-peroxidase and dermatitis herpetiformis.
    Ljunghall K; Juhlin L; Edqvist LE; Plantin LO
    Acta Derm Venereol; 1984; 64(6):546-7. PubMed ID: 6084931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylator phenotype, minimal maintenance dose and haemolytic effect of dapsone in dermatitis herpetiformis.
    Förström L; Mattila MJ; Mustakallio KK
    Ann Clin Res; 1974 Oct; 6(5):308-10. PubMed ID: 4447343
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin E for dapsone-induced headache.
    Cox NH
    Br J Dermatol; 2002 Jan; 146(1):174. PubMed ID: 11841391
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glutathione reductase deficiency in Duhring's dermatitis herpetiformis].
    Benöhr HC; Huelsekopf D; Kohn R
    Hautarzt; 1973 Aug; 24(8):347-50. PubMed ID: 4741271
    [No Abstract]   [Full Text] [Related]  

  • 8. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hemopexin in patients with dermatitis herpetiformis on dapsone (di(4-aminophenyl)sulphone).
    Kastrup W; Lindstedt G; Lundberg PA; Mobacken H
    Arch Dermatol Res (1975); 1975 Dec; 254(3):225-32. PubMed ID: 1211972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone and human polymorphonuclear leucocyte chemotaxis in dermatitis herpetiformis.
    Millar BW; Macdonald KJ; Macleod TM; Raffle EJ
    Acta Derm Venereol; 1984; 64(5):433-6. PubMed ID: 6208726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].
    Révész K; Schneider I
    Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E and dapsone-induced hemolysis.
    Smith KC
    CMAJ; 1994 Jan; 150(2):128. PubMed ID: 8287332
    [No Abstract]   [Full Text] [Related]  

  • 13. Anterior ischaemic optic neuropathy associated with Dapsone.
    Chalioulias K; Mayer E; Darvay A; Antcliff R
    Eye (Lond); 2006 Aug; 20(8):943-5. PubMed ID: 16215545
    [No Abstract]   [Full Text] [Related]  

  • 14. Anaemia in dermatitis herpetiformis. The role of dapsone-induced haemolysis and malabsorption.
    Cream JJ; Scott GL
    Br J Dermatol; 1970 Apr; 82(4):333-42. PubMed ID: 5441766
    [No Abstract]   [Full Text] [Related]  

  • 15. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy.
    Rhodes LE; Tingle MD; Park BK; Chu P; Verbov JL; Friedmann PS
    Br J Dermatol; 1995 Feb; 132(2):257-62. PubMed ID: 7888363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and haemolytic effect of dapsone and its metabolites in man.
    Halmekoski J; Mattila MJ; Mustakallio KK
    Med Biol; 1978 Aug; 56(4):216-21. PubMed ID: 703406
    [No Abstract]   [Full Text] [Related]  

  • 17. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
    Hörnsten P; Keisu M; Wiholm BE
    Arch Dermatol; 1990 Jul; 126(7):919-22. PubMed ID: 2360840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The haemolytic action of dapsone: changes in the red-cell membrane.
    Rasbridge MR; Scott GL
    Br J Haematol; 1973 Feb; 24(2):183-93. PubMed ID: 4713625
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of sulfones in the treatment of dermatitis herpetiformis with particular reference to adverse effects].
    Pawlik H; Placek W; Kwietniak K
    Przegl Dermatol; 1980; 67(2):221-7. PubMed ID: 6996039
    [No Abstract]   [Full Text] [Related]  

  • 20. [Polyneuropathy in Duhring dermatitis herpetiformis].
    Dillmann U; Krämer G; Goebel HH
    Nervenarzt; 1991 Aug; 62(8):516-8. PubMed ID: 1944718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.